Table I.
Parameter | Value |
---|---|
Total patients, n | 372 |
Gender, n (%): | |
Female | 234 (62.9) |
Male | 138 (37.1) |
Age, mean ± SD (range) [years] | 12.65 ±3.39 (4–17) |
Duration of abdominal pain, mean ± SD (range) [months] | 15.11 ±16.20 (3–120) |
Patients using PPI, n (%) | 32 (8.6) |
Patients with constipation, n (%) | 57 (15.3) |
History of H. pylori infection and/or ulcer disease in family, n (%) | 123 (33.0) |
Patients with alarm symptoms, n (%): | |
Elevated ESR | 19 (5.1) |
Anemia | 25 (6.7) |
Dysphagia | 58 (15.5) |
Persistent vomiting | 21 (5.6) |
Weight loss | 32 (8.6) |
Awakens from sleep | 113 (30.3) |
Growth failure | 30 (8.0) |
Chronic diarrhea | 6 (1.6) |
Rectal bleeding | 9 (2.4) |
Unexplained fever | 2 (0.5) |
Endoscopic-histopathological findings, n (%): | |
H. pylori gastritis | 131 (35.2) |
Erosive gastritis | 11 (2.9) |
Gastric ulcer | 7 (1.9) |
Duodenal ulcer | 23 (6.1) |
Reflux esophagitis | 32 (8.6) |
Eosinophilic esophagitis | 2 (0.5) |
Eosinophilic gastroenteritis | 2 (0.5) |
Crohn’s disease | 1 (0.3) |